GWAS for IgA Nephropathy
Demographics (4)
- SEX - Gender of participant (phv00520166.v1.p1)
- SEX - Gender of participant (phv00218099.v1.p1)
- SEX - Gender of participant (phv00520164.v1.p1)
- SEX - Gender of participant (phv00164712.v1.p1)
Disease Events (1)
- STATUS - Case/Control status for IgA nephropathy (IgAN) (phv00520168.v1.p1)
Race and Ethnicity (3)
- ETHNICITY - Ethnicity of participant (phv00520167.v1.p1)
- ETHNICITY - Self-identified ethnicity of participant (phv00218100.v1.p1)
- ETHNICITY - Self-identified ethnicity of participant (phv00164713.v1.p1)
Other (12)
- ANALYTE_TYPE - Analyte Type (phv00164716.v3.p1)
- BODY_SITE - Body site where sample was collected (phv00164715.v3.p1)
- COHORT - Cohort information (phv00520169.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00164706.v3.p1)
- COUNTRY - Country of origin of participant (phv00218101.v1.p1)
- SAMPID - Sample ID (phv00164714.v3.p1)
- SAMPID - Sample ID (phv00164709.v3.p1)
- SUBJID - De-identified Subject ID (phv00520165.v1.p1)
- SUBJID - De-identified Subject ID (phv00218098.v1.p1)
- SUBJID - Subject ID (phv00164705.v3.p1)
- SUBJID - De-identified Subject ID (phv00164711.v1.p1)
- SUBJID - Subject ID (phv00164708.v3.p1)